Your browser doesn't support javascript.
loading
Australian general practitioners' attitudes and knowledge of sentinel lymph node biopsy in melanoma management.
Watts, Caroline G; Smith, Andrea L; Robinson, Sam; Chang, Chiao-Han (Sharon); Goumas, Chris; Schmid, Helen; Kelly, John W; Hong, Angela M; Scolyer, Richard A; Long, Georgina V; Spillane, Andrew J; Henderson, Michael; Gyorki, David E; Mar, Victoria J; Morton, Rachael L; Saw, Robyn PM; Varey, Alex H; Mann, Graham J; Thompson, John F; Cust, Anne E.
Afiliação
  • Watts CG; MPH, PhD, Research Fellow, Cancer Epidemiology and Prevention Research, Sydney School of Public Health, The University of Sydney, NSW; Research Fellow, Surveillance, Evaluation and Research Program, Kirby Institute, UNSW, NSW.
  • Smith AL; MPH, PhD, Research Fellow, Centre for Healthcare Resilience and Implementation Science (CHRIS), Australian Institute of Health Innovation (AIHI), Faculty of Medicine and Health Sciences, Macquarie University, NSW.
  • Robinson S; BAppPH, Research Officer, Cancer Epidemiology and Prevention Research, Sydney School of Public Health, University of Sydney, NSW.
  • Chang CS; MD, Research Assistant, Cancer Epidemiology and Prevention Research, Sydney School of Public Health, University of Sydney, NSW.
  • Goumas C; MPH, Biostatistician, Cancer Epidemiology and Prevention Research, Sydney School of Public Health, University of Sydney, NSW.
  • Schmid H; MPH, Co-ordinator, Melanoma Research Program, Westmead institute for Medical Research, NSW.
  • Kelly JW; MD, Adjunct Professor, Monash University Department of Medicine at Alfred Health, Consultant Dermatologist, Victorian Melanoma Service, Melbourne, Vic.
  • Hong AM; MBBS, MMed, PhD, FRANZCR, Radiation Oncologist, Melanoma Institute Australia, Chris O'Brien Lifehouse, Mater Hospital North Sydney, NSW; Clinical Professor, Medicine, Central Clinical School, University of Sydney, NSW.
  • Scolyer RA; MD, Co-Medical Director, Melanoma Institute Australia, University of Sydney, Sydney, NSW; Clinical Professor, Discipline of Pathology, Faculty of Medicine and Health, University of Sydney, Sydney, NSW; Senior Staff Specialist in Anatomical Pathology, Tissue Pathology and Diagnostic Oncology, Royal P
  • Long GV; BSc, PhD, MBBS, FRACP, Co-Medical Director, Melanoma Institute Australia, Vic; Chair of Melanoma Medical Oncology and Translational Research, Melanoma Institute Australia and Royal North Shore Hospital, University of Sydney, NSW.
  • Spillane AJ; MD, FRACS, Professor of Surgical Oncology, Northern Clinical School, School of Medicine, Faculty of Medicine and Health, University of Sydney, NSW; Surgical Oncologist, Royal North Shore and Mater Hospitals, North Sydney, NSW.
  • Henderson M; MBBS, BMedSc, MD, FRACS, Professor of Surgery, University of Melbourne, Vic; Surgeon, Melanoma and Skin Service, Breast Service and Sarcoma Service, Peter MacCallum Cancer Centre, Vic.
  • Gyorki DE; MBBS, MD, FRACS, Consultant surgeon, Peter MacCallum Cancer Centre, Vic.
  • Mar VJ; PhD, Director, Victorian Melanoma Service, Alfred Hospital, Melbourne, Vic; Adjunct Associate Professor, School of Public Health and Preventive Medicine, Monash University, Melbourne, Vic.
  • Morton RL; MScMed, PhD (Clin Epi) (Hons), Director of Health Economics, NHMRC Clinical Trials Centre, Sydney Medical School, University of Sydney, NSW; Professor of Health Economics, Sydney Medical School, University of Sydney, NSW.
  • Saw RP; FRACS, MS, MBBS, Associate Professor in Surgery, Central Clinical School, University of Sydney, NSW; Surgical Oncologist, Melanoma Institute Australia, NSW; General Surgeon, Royal Prince Alfred Hospital, NSW.
  • Varey AH; BSc (Med), MBBS (Hons), FRACP, PhD, Medical Oncologist, Melanoma Institute Australia, Royal North Shore and Mater Hospitals, NSW; Associate Professor, Melanoma Medical Oncology, University of Sydney, NSW.
  • Mann GJ; MBBS, PhD, FRACP, Director, John Curtin School of Medical Research, Australian National University, ACT; Principal Investigator, Melanoma Institute Australia, University of Sydney, NSW.
  • Thompson JF; MD, Chairman, Australian Melanoma Clinical Practice Guidelines Working Party; Professor of Melanoma and Surgical Oncology, University of Sydney, Sydney, NSW; Surgeon, Royal Prince Alfred Hospital and Melanoma Institute Australia, Sydney, NSW. john.thompson@melanoma.org.au.
  • Cust AE; MPH (Hons), PhD, Head of Cancer Epidemiology and Prevention Research Group, Sydney School of Public Health and Melanoma Institute Australia, University of Sydney, NSW; Professor of Cancer Epidemiology, Sydney Medical School, University of Sydney, NSW.
Aust J Gen Pract ; 49(6): 355-362, 2020 06.
Article em En | MEDLINE | ID: mdl-32464734

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Conhecimentos, Atitudes e Prática em Saúde / Biópsia de Linfonodo Sentinela / Clínicos Gerais / Melanoma Tipo de estudo: Guideline / Observational_studies / Prevalence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Oceania Idioma: En Revista: Aust J Gen Pract Ano de publicação: 2020 Tipo de documento: Article País de publicação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Conhecimentos, Atitudes e Prática em Saúde / Biópsia de Linfonodo Sentinela / Clínicos Gerais / Melanoma Tipo de estudo: Guideline / Observational_studies / Prevalence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Oceania Idioma: En Revista: Aust J Gen Pract Ano de publicação: 2020 Tipo de documento: Article País de publicação: Austrália